LASA SUPERGENERICS
Back to Cashflow Statement
|
LASA SUPERGENERICS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹2.14 Cr | ₹-17 Cr | ₹9.21 Cr | ₹41 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of LASA SUPERGENERICS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2024 | ₹2.14 Cr |
| Mar2023 | ₹-17 Cr |
| Mar2022 | ₹9.21 Cr |
| Mar2021 | ₹41 Cr |
| Mar2020 | ₹14 Cr |
How is Cash Flow from Operating Activities of LASA SUPERGENERICS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2024 | ₹2.14 Cr | Positive | |
| Mar2023 | ₹-17 Cr | Negative | |
| Mar2022 | ₹9.21 Cr | -77.70 | |
| Mar2021 | ₹41 Cr | 203.24 | |
| Mar2020 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹42.2 Cr | -3% | 22.6% | -55.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,332.0 Cr | 4.7% | -0.3% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,800.0 Cr | 2.3% | 6.8% | 9.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,578.0 Cr | 2.5% | -1.7% | 26.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,075.0 Cr | 11.3% | 7.6% | 12.5% | Stock Analytics | |
| CIPLA | ₹105,662.0 Cr | 5.9% | 7.3% | -14.1% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -3% |
22.6% |
-55.4% |
| SENSEX | -3% |
5.8% |
-3.4% |
You may also like the below Video Courses